Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Court finds no Vaccines-autism link.

Human vaccines·2022

Same author

Agenus‘ genital herpes vaccine significantly reduces viral burden in Phase 2.

Human vaccines & immunotherapeutics·2015

Same author

The latest on PaxVax’ and Gotovax AB’s cholera vaccine candidates.

Human vaccines & immunotherapeutics·2015

Same author

ACIP ponders recommendation for Prevnar use in seniors.

Human vaccines & immunotherapeutics·2015

Same author

Letter from the editor.

Human vaccines & immunotherapeutics·2014

Same author

Letter from the editor.

Human vaccines & immunotherapeutics·2014

Same journal

Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.

Human vaccines·2012

Same journal

Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?

Human vaccines·2011

Same journal

Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.

Human vaccines·2011

Same journal

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.

Human vaccines·2011

Same journal

Fighting against infectious diseases in China.

Human vaccines·2011

See all related articles

Search research articles

Related Experiment Video

Updated: May 28, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Next generation vaccines.

Eva M Riedmann¹

¹Landes Bioscience, Vienna, Austria. eva@landesbioscience.com

|October 18, 2011

Summary

This summary is machine-generated.

The Next Generation Vaccines conference in Vienna convened experts to discuss vaccine development, manufacturing, and public health. Key topics included novel vaccine candidates and overcoming industry challenges in vaccinology.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Area of Science:

Vaccinology and Biotechnology
Public Health Policy
Pharmaceutical Manufacturing

Background:

The conference focused on advancements and challenges in the vaccine industry.
It brought together approximately 100 delegates, including biotech and industry professionals.
The event aimed to foster knowledge exchange on vaccine development and distribution.

Framework:

The program covered the future of vaccines, manufacturing processes, and distribution strategies.
It included expert presentations on regulatory affairs and public health considerations.
Case studies highlighted novel vaccine candidates in various developmental phases.

Implementation:

Top industry experts shared practical solutions and real-world experiences.
Interactive workshops and panel discussions facilitated engagement on current vaccine topics.
The conference provided a platform for discussing timely and controversial issues in vaccinology.

Implications:

The meeting facilitated the sharing of best practices and innovative approaches in vaccine science.
It addressed critical aspects of vaccine production, delivery, and regulatory compliance.
Discussions aimed to advance the field of vaccinology and improve global public health outcomes.